Brian Cushing’s spectacular 2009 rookie season with the Houston Texans was overshadowed by a failed performance-enhancing-substances test. In September 2009, Cushing tested positive for abnormally high levels of human chorionic gonadotropin (hCG), a hormone the NFL treated as a violation of its performance-enhancing substances policy. The result became public in May 2010, after Cushing had already posted 133 tackles, four sacks, four interceptions, two forced fumbles, a Pro Bowl selection, and the NFL Defensive Rookie of the Year award. He had previously denied rumors that he used performance enhancers and continued to deny ingesting or injecting any such substances, suggesting that the hCG could have been connected to an undiagnosed cancerous tumor and saying he would undergo additional medical testing. The NFL nevertheless imposed a four-game suspension to begin the 2010 season. The scandal produced an unusual awards aftershock: the Associated Press held a revote for Defensive Rookie of the Year, but Cushing still received the most votes and retained the honor. His second-team All-Pro designation, however, was rescinded, leaving his historic rookie campaign permanently marked by the failed test. Cushing later returned to the field and became Houston’s all-time leading tackler, but in September 2017 he received an even longer ten-game suspension for a second violation of the NFL’s performance-enhancing substances policy. The repeat offense further damaged his reputation and came near the end of a career already disrupted by major knee and leg injuries; the Texans released him after the 2017 season.
Follow the sources
Status and citations are supplied by the archive. AI concept art is an interpretation, not historical evidence.